Mochi is a clinically rich program with a confusing bill. Included video visits and a dietitian are genuine strengths, and its ~15.6k reviews average 4.4. But the true monthly cost is higher than the advertised $99 once the membership is added, and it does not name its current compounding pharmacy.
Mochi Health at a glance
- Category:
- Telehealth weight-loss (GLP-1)
- Medication:
- Compounded semaglutide & tirzepatide (not FDA-approved)
- Semaglutide:
- ~$99/mo medication + ~$79/mo membership
- Tirzepatide:
- ~$199/mo medication + membership
- Membership fee:
- ~$79/mo (discounted first month)
- Pharmacy:
- Not currently named
- Trustpilot:
- 4.4 / 5 · ~15,600 reviews
- States:
- All 50 + DC
- Clinical model:
- Live video visits + included registered dietitian
- Regulatory note:
- Eli Lilly lawsuit (2025, status evolving); former pharmacy closed 2025
Pros and cons
What we like
- Live video visits with board-certified providers
- Registered dietitian included — strong clinical depth
- Large review base (~15,600) averaging 4.4
- Low advertised medication price ($99 semaglutide)
- All 50 states + DC
Trade-offs to know
- Two-part bill: medication price plus a separate ~$79/mo membership
- Does not name its current compounding pharmacy
- Restrictive refund policy reported by users
- Shipping-delay complaints
- Medication is compounded — not FDA-approved
Scorecard
Scored on the same five-criterion rubric we apply to every provider. Weights in parentheses.
Pricing: watch the membership
Mochi advertises compounded semaglutide around $99/mo, one of the lowest sticker prices in our comparison. But it bills a separate ~$79/mo membership (discounted for the first month), so the true monthly cost lands closer to $178. Tirzepatide is advertised near $199/mo plus the membership. If you value a single predictable number, a flat all-in program will be easier to budget; if you want the lowest medication sticker and don't mind the two-part bill, Mochi is competitive.
Pharmacy & sourcing
Mochi does not currently name its compounding pharmacy. Its former pharmacy, Aequita, closed in April 2025 following a Washington Department of Health action reported by regional news outlets. Because compounded drugs are not FDA-approved, an undisclosed pharmacy removes a key way for patients to verify sourcing and request a certificate of analysis. This is the main reason Mochi scores lower than its clinical quality alone would suggest.
Reviews & reputation
Mochi's Trustpilot rating is 4.4 / 5 across roughly 15,600 reviews — a large, generally positive base and one of Mochi's clearest strengths. Reported negatives cluster around billing and refunds rather than clinical care. BBB grades vary across sources; check current listings.
Regulatory context
Eli Lilly filed a lawsuit involving Mochi in 2025 (the initial complaint was dismissed in October 2025 and an amended complaint has proceeded; status is evolving — verify current dockets). Coverage of the former pharmacy's closure appeared in regional outlets in 2025–2026. We note these because regulatory posture is part of our rubric; we present them factually, not as accusations.
Who Mochi is best for
Choose Mochi if you specifically want live video visits and a dietitian, and you're comfortable with a two-part bill. Consider our #1 pick instead if you want one flat, predictable price and a provider that names its pharmacy — see our MaxLife review.
Mochi Health FAQ
How much does Mochi Health really cost?
Mochi advertises compounded semaglutide around $99/mo, but it also bills a separate membership (about $79/mo after a discounted first month), so the true monthly cost is closer to $178. Compounded tirzepatide is advertised near $199/mo plus the membership. Verify current pricing on joinmochi.com.
Does Mochi Health name its compounding pharmacy?
Not currently. Mochi does not publicly name its current compounding pharmacy. Its former pharmacy, Aequita, closed in April 2025 after a Washington Department of Health action. Because compounded drugs are not FDA-approved, an undisclosed pharmacy removes a key way to verify sourcing.
Is Mochi Health FDA-approved?
Mochi's compounded semaglutide and tirzepatide are not FDA-approved and have not been reviewed by the FDA for safety, effectiveness, or quality. Compounded semaglutide is not Ozempic® or Wegovy®; compounded tirzepatide is not Mounjaro® or Zepbound®.